Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pelvic Neoplasms × Vorinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Lymphoma, Large B-Cell, Diffuse 14 Lymphoma 14 Lymphoma, Non-Hodgkin 13 Hodgkin Disease 13 Multiple Myeloma 12 Lymphoma, Mantle-Cell 11 Lymphoma, Follicular 11 Carcinoma, Non-Small-Cell Lung 11 Breast Neoplasms 10 Leukemia, Lymphocytic, Chronic, B-Cell 9 Glioblastoma 9 Lymphoma, B-Cell, Marginal Zone 8 Burkitt Lymphoma 8 Brain Neoplasms 8 Sezary Syndrome 7 Lymphoma, T-Cell, Cutaneous 7 Congenital Abnormalities 7 Unspecified Adult Solid Tumor, Protocol Specific 6 Recurrence 6 Mycosis Fungoides 6 Lymphoma, Large-Cell, Immunoblastic 6 Lymphoma, Large-Cell, Anaplastic 6 Leukemia 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Neuroblastoma 5 Neoplasms 5 Myeloproliferative Disorders 5 Myelodysplastic Syndromes 5

Interventions

Surveys and Questionnaires 2 Gemcitabine 2 spartalizumab 1 liposomal doxorubicin 1 Watchful Waiting 1 Vorinostat 1 Sunitinib 1 Radiosurgery 1 Particle Accelerators 1 Paclitaxel 1 Lidocaine 1 Ketamine 1 Iohexol 1 Immunotherapy, Adoptive 1 FS 069 1 Embolization, Therapeutic 1 Drug Therapy 1 Carboplatin 1 Blood Coagulation Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455351 2023-05-08

PRAVO

Oslo University Hospital

Phase 1 Completed

Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡